India Proposes Approval For Pharmacy Ads

The Indian health ministry has proposed that pharmacies and drug distributors may need approval to advertise prescription medicines, extending existing restrictions on pharmaceutical manufacturers. This proposal aims to restrict advertising of certain prescription medicines, including antibiotics and psychotropic drugs, without prior government approval.

Currently, pharmaceutical manufacturers cannot advertise drugs covered under Schedules H, H1 and X without prior government approval. The proposed restriction would extend to holders of retail and wholesale drug licences and other entities involved in the sale and distribution of medicines.

The proposal has been notified through a government notification following recommendations of the Drugs Technical Advisory Board (DTAB). The ministry has proposed inserting a new sub-rule (22) under Rule 65 of the Drugs Rules, 1945, to extend the restriction to these entities.

The restriction covers prescription medicines, including certain antibiotics and psychotropic drugs, which require medical supervision. This move is intended to regulate the advertising of such medicines and ensure that they are not promoted without proper oversight.

## Why it matters The proposal is significant as it aims to prevent the misuse of prescription medicines, including antibiotics and psychotropic drugs. The Indian health ministry's move to extend the restriction to pharmacies and drug distributors is a step towards regulating the advertising of such medicines and ensuring public health and safety. The proposed rule change will affect various stakeholders, including pharmacies, drug distributors, and pharmaceutical manufacturers, and will likely have implications for the way prescription medicines are advertised and promoted in India.